When was VasoGenix Pharmaceuticals founded?

VasoGenix Pharmaceuticals was founded in 2001 and raised its 1st funding round 7 years after it was founded.

Where is VasoGenix Pharmaceuticals located?

VasoGenix Pharmaceuticals is headquartered in Lenexa, United States.

Is VasoGenix Pharmaceuticals a funded company?

VasoGenix Pharmaceuticals is a funded company, having raised a total of $600K across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on 2008.

When was the latest funding round of VasoGenix Pharmaceuticals?

VasoGenix Pharmaceuticals' latest funding was a $***** Grant (prize money) round on Jan 29, 2009, with participation from 1 investor. Its primary sector is Cardiac and Vascular Disorders. In United States, the Cardiac and Vascular Disorders sector has seen $1.1B in funding in 2026 to date.

Where does VasoGenix Pharmaceuticals rank among its competitors?

VasoGenix Pharmaceuticals ranks 284th amongst 370 active competitors, of which 112 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Rejuvenate Bio, which secured $19.5M in Jun, 2026.

Who are the top competitors of VasoGenix Pharmaceuticals?

VasoGenix Pharmaceuticals' top competitors include argenx, Tenaya Therapeutics and Vor Biopharma. Among them, Rejuvenate Bio secured the most recent funding round in June, 2026.

VasoGenix Pharmaceuticals - 2026 Company Profile, Funding & Competitors

VasoGenix Pharmaceuticals is an early stage company based in Lenexa (United States), founded in 2001. It operates as a Biotechnology company specializing in reagents, kits, and assays for life science research. VasoGenix Pharmaceuticals has raised $600K in funding. The company has 370 active competitors, including 112 funded and 105 that have exited. Its top competitors include companies like argenx, Tenaya Therapeutics and Vor Biopharma.

Company Details

Biotechnology company specializing in reagents, kits, and assays for life science research. They offer a wide array of products including DNA isolation kits, assay kits, antibodies, recombinant proteins, and NATtrol medium & serums. Their offerings cater to biology, cell culture, and PCR-related research. They provide tools for studying blood-brain barrier function, vasogenic edema, and neurological disorders. The company supports scientific advancement by providing essential research tools and resources. They are involved in the development and distribution of reagents and kits for various research applications. Their products are used in diverse areas such as immunology, molecular biology, and diagnostics. They also provide blogging content related to their products and research areas.

Key Metrics

Founded Year

2001

Location

Lenexa, United States

Stage

Early Stage

Total Funding

$600K in 2 rounds

Latest Funding Round

Grant (prize money), Jan 29, 2009, $*****

Investors

Kansas Bioscience Authority & 1 more

Ranked

284^th among 370 active competitors

Similar Companies

Tenaya Therapeutics & 349 more

View VasoGenix Pharmaceuticals' full profile

VasoGenix Pharmaceuticals has raised a total funding of $600K over 2 rounds. Its first funding round was on 2008. Its latest funding round was a Grant (prize money) round on Jan 29, 2009 for $*****. 1 investor participated in its latest round. VasoGenix Pharmaceuticals has 2 institutional investors.

Here is the list of recent funding rounds of VasoGenix Pharmaceuticals:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 29, 2009	5808715	Grant (prize money)	2521837	4893263	4651195	3996427
2008	1946	Grant (prize money)	9870	1817	9472	Kansas Bioscience Authority

Access funding benchmarks and valuations. Sign up today!

View details of VasoGenix Pharmaceuticals's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of VasoGenix Pharmaceuticals include argenx, Tenaya Therapeutics and Vor Biopharma. Here is the list of Top 10 competitors of VasoGenix Pharmaceuticals, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	argenx 2008, Ghent (Belgium), Public	Developer of antibody-based drugs to treat autoimmune diseases and cancer	$61.9M	Life Sciences Partners, Seventure Partners ... & 21 others	75/100
2nd	Tenaya Therapeutics 2016, San Francisco (United States), Public	Developer of regenerative and gene therapeutics for heart failure	$248M	RTW Investments, Fidelity Investments & 7 others	70/100
3rd	Vor Biopharma 2019, Cambridge (United States), Public	Developer of therapeutics to treat acute myeloid leukemia	$152M	NEXTBio, Mingxin Capital & 10 others	68/100
4th	Kiniksa Pharmaceuticals 2015, Lexington (United States), Public	Developer of therapeutics for multiple diseases treatment	$320M	Fidelity Investments, Sofinnova Investments ... & 8 others	66/100
5th	Ventyx Biosciences 2018, Encinitas (United States), Acquired	Developer of therapeutics to treat autoimmune diseases	$165M	VenBio, Logos Capital & 13 others	66/100
6th	Esperion Therapeutics 1998, Ann Arbor (United States), Acquired	Developer of lipoprotein cholesterol (LDL-C) lowering therapies	$107M	Alta Partners, Longitude Capital & 16 others	66/100
7th	Structure 2017, San Francisco (United States), Public	Developer of oral small molecule drugs for chronic diseases	$191M	BVF Partners, Janus Henderson Investors & 17 others	65/100
8th	Cellino 2017, Cambridge (United States), Series A	Developer of autologous cell therapies	$125M	Humboldt Fund, Leaps by Bayer & 7 others	65/100
9th	Radius Health 2003, Boston (United States), Acquired	Biopharmaceutical company focused on bone health and related therapeutic areas	$213M	MPM BioImpact, Wellcome & 14 others	63/100
10th	Rejuvenate Bio 2018, San Diego (United States), Series A	Developer of gene therapies for treating chronic and age-related diseases	$34M	VCapital, Digitalis Ventures & 12 others	63/100
284th	VasoGenix Pharmaceuticals 2001, Lenexa (United States), Early Stage	Biotechnology company specializing in reagents, kits, and assays for life science research	$600K	Kansas Bioscience Authority, Wichita Technology Corporation ... Read more	24/100